Archives: Contractor Email

Dear Colleague,

Further concessionary prices have been granted for August 2020:

Drug Pack Size Concessionary Price
Adrenaline (base) 150micrograms/0.15ml (1 in 1,000) solution for injection pre-filled disposable devices 1 £34.30
Duloxetine 20mg gastro-resistant capsules 28 £7.74
Duloxetine 40mg gastro-resistant capsules 56 £12.39
Enalapril 20mg tablets 28 £7.20
Exemestane 25mg tablets 30 £41.00
Imipramine 25mg tablets 28 £6.40
Irbesartan 150mg tablets 28 £6.80
Moxonidine 200microgram tablets 28 £9.72
Moxonidine 400microgram tablets 28 £12.13
Naftidrofuryl 100mg capsules 84 £6.99
Olanzapine 20mg tablets 28 £6.77
Prednisolone 10mg tablets 30 £16.22
Prednisolone 2.5mg tablets 30 £4.19
Senna 7.5mg tablets 60 £2.76
Sertraline 50mg tablets 28 £5.27
Tolterodine 1mg tablets 56 £16.43

Kind regards,

Katherine

SENT FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development

*** FAO Independent Contractors who have not Responded ***

Dear Colleague,

We are following up with pharmacies who have not, as yet, responded to the test email sent by your local HSCB office on 19th March 2020. We have attached the relevant correspondence relating to this and a copy of the test email is provided below.

Subject: HSCB Test Email & Communication Policy – Please Respond

Dear Colleague,

This is a test email issued via the HSCB to both provide you with a copy of the Primary Care Email Communication Policy and test access to your HSC Secure Email for the first time. 

Please read the attached Primary Care Email Communications Policy and respond to this email confirming receipt and agreement with the policy.  Once your response to this

email confirming agreement with the communications policy has been received, the HSCB will be in a position to commence email communications with your pharmacy

(all communications issued via email will also be issued via hard copy post for a period of time).

If there is anything you would like to discuss in relation to the HSC secure email for community pharmacies or the attached communications policy, please contact your local Practice

Support Manager in the first instance.  If you can access this email and are content with the attached communications policy, simply reply to this email address confirming receipt

and acceptance of the communications policy.  The HSCB will then commence email communications with your pharmacy using your HSC secure email address (with information

additionally being issued via hard copy post for a limited period of time).

We appreciate this came at an extremely busy time for community pharmacy and are also aware that some technical difficulties have been experienced, we hope these issues have now been resolved.

The use of secure email will be particularly important to support services from September onwards, including the new HSC commissioned flu vaccination service, it will also form a critically important means of communication within a potential COVID-19 second wave.

We would strongly encourage you to take steps to get connected by responding to the test email sent by HSCB on 19th March 2020 as soon as possible.

If you are having any difficulties please contact your local HSCB office to get these addressed.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

Dear Colleague,

The following concessionary prices have been granted for August 2020:

Drug Pack Size Concessionary Price
Amiodarone 200mg tablets 28 £2.41
Donepezil 10mg tablets 28 £2.13
Enalapril 10mg tablets 28 £3.95
Estradiol 1mg tablets 84 £6.89
Estradiol 2mg tablets 84 £6.89
Sertraline 100mg tablets 28 £10.49
Tolterodine 2mg tablets 56 £13.99
Valaciclovir 500mg tablets 10 £20.59
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 £11.78

This is the first update of concessionary prices for August 2020.

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing.

Concessionary prices are also published on the CPNI website www.communitypharmacyni.co.uk

Kind regards,

Katherine

SENT FOR AND BEHALF OF KATHERINE KIDD | Head of Pharmacy Development

*** URGENT REMINDER ***

***IMPORTANT – FLU VACCINATION SERVICE 2020/21 OPPORTUNITY ****

Dear Contractor

Please find attached an Expressions of Interest letter and a Service Contract to be completed by all contractors wishing to provide a commissioned Flu Vaccination Service in 2020/21. Contractors offering to provide the service are required to do so in line with the National Minimum Standards and Core Curriculum for Immunisation Training, Flu Vaccination Service Specification and have an appropriate standard operating procedure in place.

Contractors should note the tight timescale for responses, with signed contracts required to be returned by email by close of play Monday 24th August 2020.

Yours sincerely

Vanessa

Sent on behalf of Dr Vanessa Chambers | Head of Policy & Development

Download

Dear Colleague,

The Executive has designed posters for retail in relation to mandatory face masks which  have been adapted for community pharmacy.  The poster can be accessed at the following link in A4 and A3 format for download and print.  Three copies of each poster size will be supplied to each community pharmacy in the coming days via post.  A copy of each poster size is also attached to this email.

https://www.nidirect.gov.uk/publications/coronavirus-covid-19-information-posters

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

Download

+++ UPDATED SURVEY LINK +++

Dear Contractor,

Further to the email sent yesterday on behalf of Bronagh White, inviting contractors to participate in a study being undertaken at the School of Pharmacy, University of Ulster, Coleraine, we have been advised that the previous UUC survey link was experiencing technical issues. Should you wish to participate in the study, please use the following new UUC survey link: https://www.surveymonkey.co.uk/r/COVIDCP2

If you need any further information please contact bc.white@ulster.ac.uk


Bronagh White, Lecturer in Pharmacy Practice and Clinical Pharmacy, Course Director MSc in Pharmacy Management , Faculty of Life and Health Sciences, University of Ulster, Coleraine.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive

+++ Also see CU#122 Sent: Monday 17 August 2020 15:02 +++

Dear Colleague

Please see below an invitation, from Bronagh White, to Contractors to participate in a study being undertaken at the School of Pharmacy, University of Ulster, Coleraine.

From Bronagh White, Lecturer in Pharmacy Practice and Clinical Pharmacy, Course Director MSc in Pharmacy Management, Faculty of Life and Health Sciences, University of Ulster, Coleraine.

Dear Contractor,


You are invited to participate in the following study

COVID-19 An opportunity or a risk for Community Pharmacy?

https://www.surveymonkey.co.uk/r/CVD-19CommunityPharmacy

This study aims to evaluate and examine the opportunities and risks of service provision from community pharmacy in relation to the COVID-19 response. Secondary aims will explore the impact COVID-19 has had on the community pharmacy business as a whole, exploring the changes community pharmacies had to make in order to minimise the spread of the virus, ensure safety of employees while still being able to provide effective delivery of high quality patient care during the pandemic. 


You can read the participant information which will inform you about the study .

The closing date for your participation is August 31st 2020.

If you need further clarification about anything, you should contact bc.white@ulster.ac.uk

Bronagh White, Lecturer in Pharmacy Practice and Clinical Pharmacy, Course Director MSc in Pharmacy Management, Faculty of Life and Health Sciences, University of Ulster, Coleraine.

Yours sincerely

SENT FOR AND BEHALF OF GERARD GREENE | Chief Executive